Cita APA

van Brummelen, E. M. J., Levchenko, E., Dómine, M., Fennell, D. A., Kindler, H. L., Viteri, S., . . . Trigo, J. (2019). A phase Ib study of GSK3052230, an FGF ligand trap in combination with pemetrexed and cisplatin in patients with malignant pleural mesothelioma. Invest New Drugs.

Chicago Style Citation

van Brummelen, Emilie M. J., et al. "A Phase Ib Study of GSK3052230, an FGF Ligand Trap in Combination With Pemetrexed and Cisplatin in Patients With Malignant Pleural Mesothelioma." Invest New Drugs 2019.

Cita MLA

van Brummelen, Emilie M. J., et al. "A Phase Ib Study of GSK3052230, an FGF Ligand Trap in Combination With Pemetrexed and Cisplatin in Patients With Malignant Pleural Mesothelioma." Invest New Drugs 2019.